Table 2.
Comparing laboratory findings between COVID-19 and non-COVID-19 patients.
| Normal range |
Total
(N = 403) |
Non-COVID-19
(N = 118) |
COVID-19
(N = 385) |
P-value |
Adjust
P-value |
|
|---|---|---|---|---|---|---|
| Laboratory findings | ||||||
| Infection markers | ||||||
| Eosinophil percentage, % | 0.4~8 | 0.64 (0.2–1.3) | 1.1 (0.5–1.9) | 0.5 (0.2–1.2) | <0.001 | 0.007 |
| White blood cell count, g/L | 3.5~9.5 | 5.9 (4.6–7.6) | 6.65 (5.1–8.3) | 5.7 (4.6–7.4) | 0.002 | 0.045 |
| Liver injury markers | ||||||
| Albumin, g/L | 35~55 | 38.4 (35–42) | 36.8 (33–41) | 38.95 (36–42) | <0.001 | 0.041 |
| Alanine transaminase | 9~50 | 18.2 (12–29) | 16.5 (11–23) | 19 (12–29) | 0.1 | 0.272 |
| Aspartate Transaminase | 13~35 | 25.8 (19–36) | 22 (17–28) | 27.4 (20–41) | <0.001 | 0.043 |
| Heart injury markers | ||||||
| Lactate Dehydrogenase, U/L | 80~285 | 231 (180–320) | 182 (150–300) | 242.85 (200–330) | <0.001 | 0.002 |
| N-terminal pro-brain natriuretic peptide | 0~125 | 76.8 (49–240) | 65.25 (48–120) | 90.285 (49–410) | 0.067 | 0.086 |
| Blood examination | ||||||
| Activated partial thromboplastin time | 24~36 | 30.3 (28–32) | 31 (29–36) | 30.1 (28–32) | 0.0039 | 0.16 |
| Hematocrit, % | 40~50 | 39.6 (36–43) | 38.4 (34–41) | 39.85 (36–43) | 0.001 | 0.113 |
| Hemoglobin, g/L | 130~175 | 134 (120–150) | 127.5 (110–140) | 135.25 (120–150) | <0.001 | 0.031 |
| Calcium, mmol/L | 2.08~2.8 | 2.12 (2–2.2) | 2.2 (2.1–2.3) | 2.1 (2–2.2) | <0.001 | 0.075 |
| Potassium, mmol/L | 3.5~5.3 | 4 (3.7–4.3) | 3.9 (3.7–4.3) | 4.02 (3.7–4.4) | 0.25 | 0.299 |
| Sodium, mmol/L | 137~147 | 139 (136–141) | 139 (138–140) | 139 (136–141) | 0.46 | 0.474 |